Dr. Parmeshar Singh, MD is a physician-scientist , currently pursuing his PhD at the Elmezzi Graduate School of Molecular Medicine, Northwell Health, New York. His research focuses on the emerging field of exogenous mitochondrial transplantation (MTx) and its therapeutic applications in rare genetic disorders, critical illness, and chronic metabolic diseases. Dedicated to advancing MTx as a viable therapeutic platform and bridging molecular biology and translational medicine, with a particular emphasis on organ protection in hemorrhagic shock, mitochondrial repair in metabolic disorders and correction of mitochondrial dysfunction in inherited disorders.